ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX – Nasdaq
|
ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX
Nasdaq University of California (UC), Berkeley and Broad have been claiming that they were the first to invent the CRISPR technology and applied for a patent in March of 2013, and October of 2013, respectively. The Broad’s patent was issued on April 15, 2014. |
|
Jury’s out on composite floor test to choose between Palanisamy and Panneerselvam
The New Indian Express With the controversy surrounding the current impasse in State yet to abate, the suggestions of Attorney General Mukul Rohatgi to call for a composite floor test to end the deadlock ran into controversy. Here’s what it is all about. When was the … |
Courier Mail |
The biotechnology trial of the century over CRISPR patent settled in US court
Courier Mail The emergence of inexpensive and accurate gene-editing technology, known as CRISPR/Cas9, has fuelled “an explosion of new research opportunities and potential clinical applications, both heritable and non-heritable, to address a wide range of human … |
|
Japanese arms for sale
East Asia Forum The deal remains in suspended animation. Some media commentaries even suggest it is as good as ‘almost dead’. More recently, Japan has opened talks with New Zealand seeking to sell patrol and transport aircraft. The negotiations are still at the early … |